SPH3127 achieves breakthrough in upstream RAAS inhibition for hypertension
  By:DengYue International Business Division   Against the backdrop of a long-standing lack of effective interventions targeting the upstream of the renin–angiotensin–aldosterone system (RAAS) and years of structural stagnation in global hypertension treatment, China has achieved a milestone breakthrough in antihypertensive innovation. On December 9, 2025, Shanghai...
0 Yorumlar 0 hisse senetleri 136 Views 0 önizleme
Sponsorluk
Sponsorluk
Sponsorluk
google-site-verification: google037b30823fc02426.html